Levodopa – history and pharmacology

Parkinson’s as I see it: we invested tons of money to investigate dopamine agonists but couldn’t find any better than dopamine (in the form of l-dopa). The only problem is it’s pharmakokinetics. As for neurotoxicity, I still believe that the small doses used nowadays (as compared to earlier decades or in mice) fare quite well.

So we spend some time reviewing the history of levodopa and the basic pharmacology.

Here are some references:


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s